References
- Akingbule O. I. Metabolism and pharmacokinetics of of metyrapone and related pyridylketones. University of London. 1992, PhD thesis
- Akingbule O. I., Damani L. A. Metyrapone metabolite pharmacokinetics: assay method and preliminary pharmacokinetic data. Progress in Pharmacology and Clinical Pharmacology 1991; 8: 59–64
- Crooks P. A., Damani L. A., Cowan D. A. Synthesis of N-oxide derivatives of metyrapone and their detection as in vitro metabolites. Journal of Pharmacy and Pharmacology 1981; 33: 309–312
- Damani L. A., Crooks P. A., Cowan D. A. Metabolism of metyrapone. III. Formation of an α-pyridine metabolite by rat hepatic soluble enzymes. Drug Metabolism and Disposition 1981; 9: 270–273
- Damani L. A., Mitterhauser M., Zolle I., Lin G., Oehler E., Ho Y. P. Metabolic and pharmacokinetic considerations in the design of 2-phenyl substituted metyrapone derivatives: 2-methoyphenylmetyrapone as a radioligand for functional diagnosis of adrenal pathology. Nuclear Medicine and Biology 1995, (in press)
- Hays S. J., Tobes M. C., Gildersleeve D. L., Wieland D. M., Beierwaltes W. H. Structure-activity relationship study of the inhibition of adrenal cortical 11β-hydroxylase by new metyrapune analogues. Journal of Medicinal Chemistry 1984; 27: 15–19
- Liddle G. W., Island D., Lauce E. M., Harris A. P. Alterations of adrenal steroid patterns in man resulting from treatment with a chemical inhibitor of 11-β-hydroxylase. Journal of Clinical Endocrinology and Metabolism 1958; 18: 906–912
- Napoli J. L., Counsell R. E. New inhibitors of steroid 11β-hydroxylase. Structure-activity relationship studies of metyrapone-like compounds. Journal of Medicinal Chemistry 1977; 20: 762–766
- Robien W., Zolle I. Synthesis of radioiodinated metyrapone—a potential agent for functional imaging of the adrenal cortex. International Journal of Applied Radiation and Isotopes 1983; 34: 907–914
- Sarkar S. D., Cohen E. L., Beierwaltes W. H., Ice R. D., Cooper R., Gold E. N. A new and superior adrenal imaging agent, I-131–6β-iodo-methyl-19-norcholesterol (NP-59): evaluation in humans. Journal of Clinical Endocrinology and Metabolism 1977; 45: 163–172
- Temple T. E., Liddle G. W. Inhibitions of adrenal steroid biosynthesis. Annual Review of Pharmacology 1970; 10: 199–218
- Usansky J. I., Damani L. A. The urinary metabolic profile of metyrapone in the rat. Identification of two novel isomeric metyrapone N-oxide metabolites. Drug Metabolism and Disposition 1992; 20: 64–69
- Wieland D. M. Radiolabeled enzyme inhibitors—adrenocortical enzymes. Receptor-Binding Radiotracers, W. C. Eckelman. Chemical Rubber Co., Cleveland 1982; vol. I: 127–146
- Zolle I., Woldszczuk W., Höfer R. Synthesis and in vitro evaluation of metyrapone derivatives as potential inhibitors of 11β-hydroxylase activity. Radiopharmaceuticals and Labelled Compounds. Vienna 1985; 337–342, IAEA-CN-45/67
- Zolle I., Yu J., Robien W., Woloszczuk W., Höfer R. Biochemical evaluation of metyrapone derivatives—inhibition kinetics and affinity studies. Journal of Labelled Compounds and Radiopharmaceuticals 1991; 30: 420–422
- Zolle I., Halldin C., Yu J., Swahn C. G. [11C] 2-Methoxyphenylmetyrapone for PET. Journal of Labelled Compounds and Radiopharmaceuticals 1993; 32: 547–549